Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

The 2023 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of IDEAYA, or following a bona fide period of non-employment, as an ...

Sun Pharmaceutical Industries Ltd. closed 14.38% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Despite some recent reversals in trade policy, the broader trend still indicates a rise in trade barriers compared to the ...

A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...